To date, promising research suggests that variants of TOMM40 or BIN1 may be relevant for assessing the risk of Alzheimer’s disease; however, they have not yet been recognized as standard diagnostic criteria for the condition. This evidence concerns the gene TOMM40 and early-onset autosomal dominant Alzheimer disease.